Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosis

Mickael Bonnan1, Paul Money2, Pauline Desblache2

  • 1Neurologie, Centre hospitalier de Pau, 4 Bd Hauterive, 64000, Pau, France. mickael_bonnan@yahoo.fr.

Insights

Chronic leptomeningeal enhancement (LME) in multiple sclerosis (MS) may resolve, yet still contribute to cortical atrophy. Advanced MRI techniques are crucial for detecting these subtle but significant inflammatory changes in secondary progressive MS.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Chronic leptomeningeal enhancement (LME) on MRI is associated with inflammation and cortical atrophy in secondary progressive multiple sclerosis (SP MS).
  • Previous research suggests LME correlates with pathological findings of focal cortical inflammation and demyelination.

Purpose of the Study:

  • To investigate the potential for spontaneously remitting meningeal uptake in SP MS.
  • To evaluate the role of conventional MRI sequences versus T1-enhanced sequences in detecting meningeal lesions and their impact on cortical atrophy.

Main Methods:

  • Case report of a patient with SP MS experiencing spontaneously remitting meningeal uptake.
  • Utilized conventional 3-T MRI sequences (FLAIR, DIR) and T1-enhanced sequences.
  • Assessed cortical lesion visibility and quantified the rate of cortical atrophy in affected areas.

Main Results:

  • A case of spontaneously remitting meningeal uptake was observed in an SP MS patient.
  • No cortical lesions were visible on FLAIR or DIR sequences, despite higher cortical atrophy rates in the affected area.
  • T1-enhanced sequences highlighted inflammatory activity, suggesting LME's direct role in cortical atrophy.

Conclusions:

  • Conventional MRI may underestimate the burden of regressive meningeal lesions in SP MS.
  • Leptomeningeal enhancement might be an active driver of focal cortical atrophy and an early indicator of cortical lesions in SP MS.
  • T1-enhanced MRI is valuable for assessing inflammatory activity and the true impact of LME in SP MS.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...